Marching Toward 70,000 – Why More Clinical Suggestions Are Better
Learn how our team works to grow the number of clinical suggestions in our database to increase the opportunities for prescription savings.
ARTICLES
If it matters to our members, clients or pharmacy in general, RxSS will have a take on it.
- Select Category
- Chronic Conditions
- Engagement
- Events
- Healthcare Costs
- Media
- Medication Adherence
- Member Stories
- Our Team
- Privacy and Security
- Product
- Success Stories
- Thought Leadership
- Transparency
- Uncategorized
- Select Category
- Chronic Conditions
- Engagement
- Events
- Healthcare Costs
- Media
- Medication Adherence
- Member Stories
- Our Team
- Privacy and Security
- Product
- Success Stories
- Thought Leadership
- Transparency
- Uncategorized
The Adderall Shortage Is Real – Here’s How RxSS Helps Members
We know many members are scrambling to find pharmacies with the common ADHD medication in stock. With this and other drug shortages, RxSS can be an invaluable resource.
Humira Biosimilars and other Biologic Alternatives
A wave of FDA-approved biosimilars for Humira and other costly biologics will enter the U.S. market in 2023. What does it mean for patients, payers and plan designs?
Prescription Drug Options – Pharmacist Curated, Doctor Approved
Members shouldn't confuse our clinical suggestions for intervention. Medication decisions are between patient and doctor. RxSS informs those discussions, and makes it easy to make a change.
Considering a PBM’s Savings Tool? 10 Questions to Ask Right Now
Free PBM tools can help members get more from their pharmacy benefits, maybe even save on certain prescriptions. What more can you ask for? Quite a bit, actually.
Drug Cost Comparison Tools and Healthcare Cost Transparency Come to Life
Seemingly since the beginning of time, consumers have rarely known what a doctor visit, medical procedure or medication will cost until it’s time to pay. Fortunately, things are starting to change. ...
Specialty Copay Programs – Accumulate, Maximize or Avoid?
Utilization of specialty medications continues to rise, and so do costs for patients and plan sponsors. Thanks to these rising costs, we see more plans choosing to implement copay adjustment programs, ...
Why Are the Most Important Rx Decision-makers Still in the Dark?
The only people who can write prescriptions typically have no idea what patients will pay at the pharmacy. It's time to solve this problem.
Let’s Talk About Mental Health
Every May we raise awareness about mental health as we continue to help our members stay adherent by showing them affordable options for the medications they need.
Success With Point Benefit Solutions Hinges on the Pharmacy Factor
Many point benefits solutions have produced positive results for employers and health plans. However, their full potential depends on medication access and affordability.
Dexilant Generic Joins the PPI Party, But Plenty of Alternatives Already Have
A widely prescribed acid reflux medication now has an authorized generic available. Good news, but five low-cost proton-pump inhibitor (PPIs) generics often work just as well.
Whatever the Numbers Say, Guess Who Keeps Paying More for Rx?
January produced another price hike party from drug makers. But some data indicate prescription prices are actually falling. For consumers? Same as it ever was, or worse.
On One Condition – Hypothyroidism
A collection of clinical insights from our team of in-house pharmacists. These industry veterans curate, update and review our patented technology’s 34,000+ clinical, dose-adjusted savings suggestions—and they’ve got expertise to ...
Stay COnnected
Subscribe to our newsletter, for must-read industry insights delivered straight to your inbox.
